Currently out of the existing stock ratings of Katherine Breedis, 8 are a BUY (100%).

Katherine Breedis

Work Performance Price Targets & Ratings Chart

Analyst Katherine Breedis, carries an average stock price target met ratio of 25% that have a potential upside of 29.96% achieved within 1059 days. Previously, Katherine Breedis worked at STIFEL.

Katherine Breedis’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VYGR, Voyager Therapeutics at 28-Jul-2017.

Wall Street Analyst Katherine Breedis

Analyst best performing recommendations are on GILD (GILEAD SCIENCES).

Average potential price target upside

GILD Gilead Sciences VYGR Voyager Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$130

$18.21 (16.29%)

$115

6 days ago
(27-Mar-2025)

3/4 (75%)

$18.84 (16.95%)

86

Buy

$130

$18.21 (16.29%)

$123

22 days ago
(11-Mar-2025)

27/31 (87.1%)

$15.57 (13.61%)

600

Buy

$126

$14.21 (12.71%)

$109

28 days ago
(05-Mar-2025)

2/3 (66.67%)

$11.26 (9.81%)

45

Buy

$140

$28.21 (25.23%)

$120

28 days ago
(05-Mar-2025)

16/18 (88.89%)

$25.26 (22.01%)

486

Hold

$90

$-21.79 (-19.49%)

$84

1 months 21 days ago
(12-Feb-2025)

65/74 (87.84%)

$-13.31 (-12.88%)

1649

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Katherine Breedis?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?